Coalition Voice

In the search for information that is meaningful to patients, sifting through the abstracts and presentations from this highly-regarded annual symposium can be a daunting task, not unlike the proverbial needle-in-a-haystack conundrum.

A randomized, multinational, phase III clinical trial called GOG-0213, which was conducted by researchers at the MD Anderson Cancer Center, took a look at surgical cytoreduction, also known as debulking surgery, in women with recurrent ovarian cancer tumors that were small, operable, and had responded to previous platinum-based chemotherapy with a disease-free interval of at least six months.

It comes as an unwelcome surprise to many who are diagnosed with breast cancer that treatments for the disease often result in weight gain.

Danielle Erin Desa is a third-year Ph.D. student working with the laboratory of Edward Brown, Ph.D. at the University of Rochester. As the 2019 recipient of the Coalition’s Pre-and-Post-Doctoral Grant for her proposal, Understanding the Mechanisms Underlying a Novel Predictor of Metastasis, she will study an optical signal produced by fibrillar collagen in breast tumors.